Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-27

Clinical Trial Update: Intravenous Paracetamol, Dexketoprofen and Ibuprofen in the Treatment of Acute Migraine Attack Headache [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the use of intravenous paracetamol, dexketoprofen, and ibuprofen for acute migraine headache treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexketoprofen (dexketoprofen)
  • Ibuprofen (IBUPROFEN)
  • Paracetamol (acetaminophen) (acetaminophen)

Snippet

Sponsor: Pamukkale University | Conditions: Headache, Migraine | Phase 4 | Status: UNKNOWN